MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore's National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies. -- S$10 million a year to be invested in SMART CAMP in a multi-year effort -- New interdisciplinary research group, SMART CAMP, will bring together 35 MIT and Singapore investigators -- Complementary and integrated programme with Singapore's Agency for Science Technology and Research (A*STAR) cell manufacturing effort, supported by the National Research Foundation (NRF) -- SMART CAMP deploys MIT's innovation methodologies in Singapore's thriving biopharmaceutical industry, tapping market potential of billions a year.
Press Release Medical Technology and Software
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") and Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN: A14XHT) (OTCQX: LDSYF) ("LDS") have mutually agreed to terminate a letter of intent ("LOI") dated June 28, 2019 whereby TransCanna was to acquire LDS. After careful review of the transaction and current market conditions, TransCanna has determined the acquisition of LDS by TransCanna under the terms of the LOI would not be in the best interests of shareholders, and as a result, the LOI has been terminated by both parties.
ovotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.
Below is a summary of the conference call held July 3, 2019 with investors, and TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) ("TransCanna" or the "Company") CEO, Jim Pakulis, outlined the Company's five phase strategy and the progress made to date:
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development.
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.
TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (OTC PINK: TCNAF) ("TransCanna" or the "Company") is pleased to announce that it has closed its previously announced brokered private placement of units, generating aggregate gross proceeds of CDN$10,001,750.
- Proteomics International meeting with US tier 1 national diagnostic groups to expand global roll-out of PromarkerD including EU and Mexico
PromarkerD world's leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report 'Biomarkers Enabling Diabetes and Obesity Management'
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs.
More than 12,000 buyers visit 2019 fair, up 8% on last year
Biotechnology applications and smart portable devices in focus
Here we are describing The Horrifying effects of Fatty Food on your Body. Check out the effect of it.
Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce today the execution of a non-binding Letter Of Intent dated April 30th, 2019 to acquire the branding asset package, Biovelle, a hemp based CBD coconut oil from an arm's length third party.
Maharshi Atreya Health Centre is a place of retreat for anyone seeking a genuine holistic experience for the well-being of body and mind. With a focus on authentic Ayurveda combined with today's possibilities of medical sciences, the Ayurvedic health centre offers best alternative to Western medicine.
We are discussing here Artificial Intelligence in the healthcare sector. The importance of Artificial Intelligence, past, present and the future and where it is using.
Hemp, Inc. (OTC PINK: HEMP) reported financial results for the quarter and full year ending December, 31, 2018. A global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.
(ACN Newswire) - ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that as of April 1, 2019, the company is selling its LAP-BAND(R) product in the Australian market through a relationship with Satori Healthcare.
Luminescing nanosized crystals are showing promise for peering deeply into body tissues, but first they need to be made safe.
It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning.
When people think of the term tourism, most associate it with either doing business or having fun. However, there is a rising trend towards traveling to other countries to receive much-needed health care.